10,897 GE HealthCare Technologies Inc. $GEHC Shares Purchased by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.9% during the third quarter, HoldingsChannel reports. The institutional investor owned 121,395 shares of the company’s stock after acquiring an additional 10,897 shares during the period. Rakuten Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $8,068,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. State Street Corp raised its position in shares of GE HealthCare Technologies by 1.6% during the second quarter. State Street Corp now owns 20,861,566 shares of the company’s stock worth $1,335,349,000 after acquiring an additional 323,090 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC lifted its stake in shares of GE HealthCare Technologies by 13.2% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock worth $861,307,000 after acquiring an additional 1,571,226 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of GE HealthCare Technologies by 2.0% in the first quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock worth $384,219,000 after acquiring an additional 105,995 shares during the period. Van ECK Associates Corp boosted its holdings in GE HealthCare Technologies by 4.1% in the second quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock valued at $286,933,000 after acquiring an additional 177,028 shares during the last quarter. Finally, Trian Fund Management L.P. boosted its holdings in GE HealthCare Technologies by 76,194.4% in the second quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock valued at $197,493,000 after acquiring an additional 3,081,300 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 2.4%

Shares of GE HealthCare Technologies stock opened at $83.78 on Friday. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.30 and a quick ratio of 1.01. The stock’s 50-day moving average is $69.12 and its 200 day moving average is $70.04. The firm has a market cap of $37.88 billion, a price-to-earnings ratio of 17.67, a PEG ratio of 2.16 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The business had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. During the same period in the previous year, the company posted $1.07 earnings per share. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 5.02 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a dividend of $0.04 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.38%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on GEHC. Citigroup increased their target price on shares of GE HealthCare Technologies from $71.00 to $79.00 and gave the company a “neutral” rating in a research report on Thursday, October 29th. Evercore restated an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. Weiss Ratings raised shares of GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, October 6th. Royal Bank Of Canada increased their price objective on shares of GE HealthCare Technologies from $80.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, October 29th. Finally, Wolfe Research assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, October 20th. They set a “peer perform” rating for the company. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $80.87.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.